Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial

Abstract

This study provides new evidence, from a randomized controlled trial, of the beneficial effect of community pharmacist intervention in the clinical management of type 2 diabetic patients. However, questions remain about the sustainability of the observed improvements.

Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial

“…Therefore, implementation of an appropriate, structured, and multidisciplinary PhC [17,18], along with patient empowerment, seems crucial for the improved glycemic control we observed. Large studies (n = 289 and 288) in Australia and Belgium with [ 50 community pharmacies evaluating PhC impact on clinical outcomes in adults with T2DM also reported HbA1c reductions (ranging 0.5-1.0 %) [33,34]. Thus, our trial further supports the value of pharmacists in a multidisciplinary team to reduce disease burden in T1DM.…”

Pharmacy care and adherence to primary and secondary prevention cardiovascular medication: a systematic review of studies

“…In 15 studies the principal setting for the intervention was a community pharmacy,7 15–17 19 21 24 29 31–35 39 44 in 14 studies the interventions were in hospital,11 12 23 26 27 30 37 38 40–42 45 47 48 and in 9 studies 8 10 13 14 18 20 22 25 28 the setting was a clinic or primary care practice. In two trials36 43 the intervention setting was the patient’s home and in one trial46 the intervention was delivered in a hospital and community pharmacist setting.…”

A Multifactorial Intervention to Enhance Adherence to Medications and Disease-Related Knowledge in Type 2 Diabetic Patients in Southern Punjab, Pakistan

“…Sample size was determined by a standard statistical formula [9] and was found to be 163 in each group. Statistical analysis was performed using statistical software SPSS version 16.0 (SPSS Inc, Chicago, Ill).…”